JPRN-UMIN000031947招募中未知
A study on multifaceted clinical effects of SGLT2 inhibitors - Multifaceted clinical effects of SGLT2 inhibitors
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 123
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criteria were: (1) hypersensitivity or a contraindication to sitagliptin or voglibose; (2) history of type 1 diabetes; (3) history of ketoacidosis; (4) having experienced symptoms of hypoglycemia; (5) treatment with sitagliptin or voglibose within 12 weeks before screening; (6) treatment with insulin within 12 weeks before screening; (7) concomitant corticosteroid therapy; (8) poorly controlled or unstable diabetes (the state with ketoacidosis or with an increase in HbA1c >3% in the 12 weeks before screening); (9) alanine aminotransferase and/or aspartate aminotransferase levels more than 2.5-fold the upper limit of normal; (10) poorly controlled hypertension or systolic blood pressure >160 mm/Hg or diastolic blood pressure >100 mm/Hg; (11) presence of a severe health problem not suitable for the study; (12) pregnancy or breastfeeding; or (13) inability to participate in the study due to psychiatric or psychosocial status as assessed by the investigators.
研究者
相似试验
招募中
不适用
The clinical study to explore the effects of SGLT2-inhibitors or DPP-4 inhibitors in Japanese patients with type 2 diabetes.Type 2 diabetesJPRN-UMIN000020984Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine160
进行中（未招募）
1 期
The effects of SGLT2-inhibition in patients with type 2 diabetes and preserved kidney function on renal circulation, kidney function and hormones related to the circulatioType 2 diabetesMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2019-004303-12-DKniversity Clinic of Nephrology and Hypertension, Regional Hospital Holstebro20
已完成
不适用
Effects of treatment with SGLT2 inhibitor on the initiation of continuous positive airway pressure therapy in type 2 diabetic patients with obstructive sleep apnea syndromeType 2 diabetesJPRN-UMIN000045226Akishima Clinic16
招募中
4 期
Effects of SGLT-2 inhibitors for the patients with non-alcoholic fatty liver disease (NAFLD) complicated with type 2 diabetes mellitus.on-alcoholic fatty liver disease (NAFLD) complicated with type 2 diabetes mellitus.JPRN-UMIN000018913Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine50
已完成
不适用
Prospective intervention study of novel SGLT-2 inhibitor ipragliflozin in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000015104Seino Naika Clinic100